ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,942Medicare Part D Prescriptions Filled, Including Refills

Rank: 117 out of 1171

$708K Total Retail Price of All Prescriptions

Rank: 96 out of 1171

594 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 594 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 594 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 7,380 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 903 428 S3 1 8
OMEPRAZOLE 434 316 2 5
LISINOPRIL 343 243 3 3
LEVOTHYROXINE SODIUM 318 203 4 4
SIMVASTATIN 292 198 5 1
ZOLPIDEM TARTRATE 262 165 6 21
AMLODIPINE BESYLATE 255 191 7 2
TRAMADOL HCL 240 129 8 18
ATENOLOL 240 195 8 15
AZITHROMYCIN 218 134 10 43
METOPROLOL TARTRATE 217 133 11 11
FUROSEMIDE 208 175 12 6
NEXIUM 181 83 13 25
GABAPENTIN 168 102 14 16
CITALOPRAM HBR 160 117 15 22
HYDROCHLOROTHIAZIDE 154 111 16 9
OXYCODONE HCL-ACETAMINOPHEN 152 48 S2 17 99
DOXYCYCLINE HYCLATE 147 97 18 137
CIPROFLOXACIN HCL 146 94 19 61
TRIAMTERENE-HCTZ 146 108 19 58
METFORMIN HCL 138 104 21 7
GLIMEPIRIDE 137 88 22 34
TAMSULOSIN HCL 130 109 23 28
ATORVASTATIN CALCIUM 124 107 24 10
PRAVASTATIN SODIUM 123 93 25 13
ALLOPURINOL 122 74 26 31
POTASSIUM CHLORIDE 122 89 26 19
LOSARTAN POTASSIUM 114 58 28 14
PANTOPRAZOLE SODIUM 97 68 29 29
CYCLOBENZAPRINE HCL 92 17 R 30 67
SYNTHROID 88 76 31 48
AMITRIPTYLINE HCL 86 25 R 32 74
WARFARIN SODIUM 85 70 33 12
CLOTRIMAZOLE-BETAMETHASONE 83 37 34 174
LYRICA 81 25 35 127
ENDOCET 81 16 S2 35 161
OXYCODONE HCL 80 0 S2 37 79
PREDNISONE 79 61 38 39
MORPHINE SULFATE ER 78 20 S2 39 146
METOPROLOL SUCCINATE 70 54 40 17
ESCITALOPRAM OXALATE 70 38 40 69
PROMETHAZINE HCL 69 0 R 42 87
SERTRALINE HCL 63 37 43 23
CYMBALTA 63 26 43 64
IBUPROFEN 62 39 45 80
CARISOPRODOL 58 0 R 46 160
CARVEDILOL 58 37 46 20
LANTUS 57 44 48 46
DICLOFENAC SODIUM 55 51 49 103
INDOMETHACIN 54 33 R 50 291
TRAZODONE HCL 54 28 50 37
CLOPIDOGREL 51 36 52 35
PLAVIX 51 37 52 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.